Research Article
The Prevalence of Metabolic Syndrome in Ethiopian Population: A Systematic Review and Meta-analysis
Table 1
Definitions of metabolic syndrome by using NCEP/ATPIII and IDF criteria.
| | NCEP/ATPIII | IDF |
| | Absolutely required | None | Central obesity (waist circumference§): 94 cm (M) and ≥80 cm (F) | | Criteria | Any three of the five criteria below | Obesity, plus two of the four criteria below | | Obesity | Waist circumference: >40 inches (M) and >35 inches (F) | Central obesity already required | | Hyperglycemia | Fasting glucose >100 mg/dl or Rx | Fasting glucose> 100 mg/dl | | Dyslipidemia | TG > 150 mg/dl or Rx | TG > 150 mg/dl or Rx | | Dyslipidemia (second, separate criteria) | HDL-C: <40 mg/dl (M) and <50 mg/dl (F) or Rx | HDL-C: <40 mg/dl (M) and <50 mg/dl (F) or Rx | | Hypertension | >130 mmHg systolic or > 85 mmHg diastolic or Rx | >130 mmHg systolic or > 85 mmHg diastolic or Rx |
|
|
Rx, pharmacologic treatment; NCEP/ATPIII, National Cholesterol Education Program–Adult Treatment Panel III; IDF, International Diabetes Federation; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol.
|
